8000 MARINA BOULEVARD, SUITE 120, BRISBANE, CA
Provides Business Update and Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Board Appointment - Christopher Hite Joins Vera Therapeutics Board
Provides Business Update and Reports Full Year 2025 Financial Results
Departure of Chief Legal Officer Jason Carter at Vera Therapeutics
Vera Therapeutics Announces Follow-On Public Offering of 6.14 Million Shares
James R. Meyers Appointed to Vera Therapeutics Board of Directors
Investor Presentation
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Correspondence
Submission Upload
S-1MEF